CN1276081C - Recombinant human aFGF production method by gene engineering expression in silkworm body - Google Patents
Recombinant human aFGF production method by gene engineering expression in silkworm body Download PDFInfo
- Publication number
- CN1276081C CN1276081C CN 200510048965 CN200510048965A CN1276081C CN 1276081 C CN1276081 C CN 1276081C CN 200510048965 CN200510048965 CN 200510048965 CN 200510048965 A CN200510048965 A CN 200510048965A CN 1276081 C CN1276081 C CN 1276081C
- Authority
- CN
- China
- Prior art keywords
- afgf
- silkworm
- recombinant
- recombinant human
- people
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention discloses a gene engineering expression method of producing recombined human acid fibroblast growth factors (aFGF) in silkworm body, which is characterized in that hybridized baculovirus HyNPV of AcNPVand BmNPVbuilt by the proposer is used as a carrier to build recombined viruses which contain human aFGF genes, and silkworm is used as the parasitifer of the recombined viruses to express the recombined human aFGF with biological activities. The present invention overcomes the defects that the expression of aFGF in colibacillus needs complicated renaturation operation, the plasmid transformant is unstable in yeast expression and the production cost is high in culturing cells in mammals. In the method of the present invention, aFGF is purified from fat body by affinity chromatography, and the output obtained from each silkworm is 600 to 700 mu g. The activity analysis indicates that recombined aFGF has the biological activities of promoting the division and proliferation of cells. In the gene engineering technology, silkworms can be used as expression carriers for producing recombined aFGF in large scale, which opens up wide prospects for the application of the recombined aFGF in the fields of medical science and treatment.
Description
Technical field
The present invention relates to genetic engineering technique, baculovirus gene expression system, protein purification and activation analysis, relate in particular to a kind of recombinant human aFGF method that gene engineering expression in silkworm body produces of being in.
Background technology
Fibroblast growth factor (fibroblast growth factor is called for short FGF) is that the heparin Heparin that a class formation is similar, biological function is close is conjugated protein.Have report to think that there are 18 members in FGF family recently, wherein, the acidity and the acid fibroblast growth factor (aFGF and bFGF) that are separated to from cow brain tissue are two members that find the earliest this family.People aFGF is made up of 140 amino acid, and molecular weight is 15.8kDa, and pI is 4.8-5.8.People aFGF all has the external short splitting action of intensive to multiple mesoblastema and the neuroderm cell that comprises vascular endothelial cell, therefore, be considered to grow in adjusting, the blood vessel in wound healing and the tumor growth process takes place and regeneration aspect have vital role.Therefore, in the clinical trial broad research people aFGF actual effect on wound healing, tissue transplantation and treatment local asphyxia, demonstrate good application prospects.Cost an arm and a leg but people aFGF is proteic in the market, though can produce in intestinal bacteria with engineered method, people aFGF need be to its folding again its biological activity of recovering with the formal representation of inclusion body in intestinal bacteria.Extra processing makes this process efficiency very low and uneconomical.In order to overcome this problem, other people once tried to express production with the mammalian cell of yeast and adenovirus infection.Yet, zymic plasmid transformant instability, Mammals culturing cell production cost is too high again.Therefore be necessary to set up the method for a kind of production people aFGF of efficient economy.
Baculovirus expression system is one of the most effective now eukaryotic gene expression system, at present this system comprises that mainly American-European countries is just at autographa california nuclear polyhedrosis virus (the Autographacalifornica nuclear polyhedrosis virus of widespread use, be called for short AcNPV) and be Bombyx mori nuclear polyhydrosis virus (the Bombyx mori nuclear polyhedrosis virus of representative with China, Japan, be called for short BmNPV) expression system two big classes, both respectively have advantage, but virus host scope difference.The AcNPV host range is wider; and " silkworm-recombinant baculovirus expression system " is owing to can utilize specialty economies insect one silkworm of China's number of animals raised maximum to make to express carrier; silkworm has characteristics such as individual big, easy raising; therefore have low, the advantage such as be produced on a large scale of production cost, be suitable for the requirement of bio-pharmaceuticals industrialization level.The applicant has made up the hybridization baculovirus HyNPV (patent No. ZL01125605.2) between BmNPV and AcNPV, and it has the outstanding advantage in the host territory of expansion.Like this, can be in the host cell Sf21 of AcNPV construction of recombinant virus, low-cost in silkworm larva then, produce recombinant protein efficiently.
Summary of the invention
The object of the present invention is to provide a kind of recombinant human aFGF to be in method that gene engineering expression in silkworm body produces.Utilize HyNPV to make up and contain the recombinant virus of people aFGF gene, and utilize silkworm, express the recombinant human aFGF that produces biologically active as the host.
In order to achieve the above object, its step of the technical solution used in the present invention is as follows:
1, recombinant human aFGF be in that gene engineering expression in silkworm body produces method, it is characterized in that:
(1) clone of people aFGF gene: with human brain cDNA is template, and the pcr gene amplification technique obtains people aFGF gene, and design of primers is as follows: forward primer: 5 '-
AGATCTTTTAATCTGCCTCC-3 ' contains the BglII restriction enzyme site; Reverse primer: 5 '-
AGATCTTTAATCAGAAGAGAC-3 ' contains the BglII restriction enzyme site.The cycle number of PCR reaction, the design of temperature and time are as follows: a circulation, 94 ℃ of template sex change 50 seconds; 30 circulations were annealed 30 seconds for 55 ℃, and 72 ℃ were extended 1 minute; Last 1 circulation, 72 ℃ were extended 10 minutes; Utilize 1% agarose gel electrophoresis to carry out the PCR product analysis, and with PCR purification kit purifying, subsequently purpose PCR product cloning is gone into 3.9kb carrier pCR2.1, obtain pCR2.1-aFGF, utilize dideoxy chain termination on the nucleotide sequencing instrument, to check order and confirm human cloning aFGF gene order exactness;
(2) contain the structure of the recombinant baculovirus of people aFGF gene: pCR2.1-aFGF obtains people aFGF gene fragment with restriction enzyme BglII digestion, is cloned into baculovirus transfer vector pAcGP67b then and obtains recombinant chou pAcGP67b-aFGF; In insect cell, produce recombinant virus by cotransfection with hybridization baculovirus HyNPVDNA homologous recombination, the method of cotransfection is: 1 μ g pAcGP67b-aFGF DNA and 15 μ g HyNPV DNA mix, and add 14 μ l liposome lipofectin, add sterile purified water at last to final volume 40 μ l; Sf 21 culturing cells with this mixed solution cotransfection logarithmic phase after room temperature is cultivated 15 minutes.Earlier after 24 hours, change the fresh culture that contains 10% foetal calf serum into, cultivated 5 days for 27 ℃, collect the substratum supernatant, be used for recombinant celo virus as virus stock solution used with the TC-100 culture medium culturing of serum-free; Recombinant virus is taken turns plaque select by 3, finally obtains the viral solution of high density purifying, and concentration is 10
8Pfu/ml is with this recombinant virus called after HyNPV-aFGF;
(3) silkworm expression in vivo and recombinant human aFGF purifying: use silkworm larva to play silkworm 5 ages, inoculate above-mentioned recombinant virus and infect expression; Preceding larva is immersed in of inoculation carried out short period of time anesthesia in the ice-water bath, adopt hypodermic method injection recombinant virus suspension then, and concentration is 10
6Pfu/ml, every silkworm is injected 20 μ l, injects and feeds mulberry after 1 hour, and raise down at 23-25 ℃; Infect collector's silkworm larva in back 72-96 hour, dissect the fatty body of infected silkworm, and with this parent material as purification of recombinant human aFGF; The pH7.6 of precooling will be dissolved in after the fatty body homogenate, in the 20mM Tris-HCl damping fluid, behind high speed centrifugation, supernatant liquor directly gone up heparin Heparin affinity column, owing to people aFGF and heparin have the intensive affinity people aFGF is attached on the chromatography column, remove foreign protein with the above-mentioned same buffer solution elution that contains 0.4M NaCl then, damping fluid one-step elution with 2.0M NaCl goes out bonded people aFGF at last, identify recombinant protein by the SDS-PAGE electrophoretic analysis, the result shows that the recombinant human aFGF purity of acquisition is very high;
(4) recombinant human aFGF activation analysis is identified: the biological activity of analyzing recombinant human aFGF with Human umbilical vein endothelial cells HUVEC: Human umbilical vein endothelial cells HUVEC is 37 ℃ of cultivations in substratum 199, replenish 5% CO
2, add 100units/ml penicillin in the substratum in addition, the 100units/ml Streptomycin sulphate, the 4.0mg/ml amphotericin B, bovine serum is added in 20% hot deactivation, 5units/ml heparin and 50mg/ml endothelial cell growth supplementation material ECGS; Above-mentioned cell is inoculated in 24 hole tissue culturing plates after with tryptic digestion, and cell density is approximately 1.0 * 10
4Cells/well, every hole adds the same substratum of 1ml.After 24 hours, substratum is replaced by contains 10%SCS and 5units/ml heparin, but do not contain the fresh culture 199 of ECGS; The recombinant human aFGF of purifying with 0.22 μ m sterilising filter filtration sterilization, joins in the above-mentioned cultivation plate hole behind gradient dilution, and every pore volume is no more than 10 μ l.After 72 hours, wash twice,, be resuspended among the 200 μ l PBS with the above-mentioned cell of centrifugal collection behind the tryptic digestion with PBS; After 0.4% the blue dyeing of phenol, calculate number of cells with hemocytometer.The result shows that recombinant human aFGF can stimulate division, the propagation of above-mentioned cell, shows that the recombinant human aFGF that expresses in the silkworm larva has biologic activity.
The present invention compares with background technology, and the beneficial effect that has is:
The present invention has solved people aFGF preferably needs in complicated renaturation manipulation, the yeast expression plasmid transformant unstable and in the too high shortcoming of Mammals culturing cell production cost at expression in escherichia coli, and silkworm larva express recombinant people aFGF has the advantage that cost is low, output is high, biological activity is strong.The method that this patent is set up can mass production recombinant human aFGF, has broad application prospects in the medical science and the clinical treatment field in future.
Embodiment
1, research material: genetically engineered operational tool enzyme and pcr amplification test kit are purchased in the living worker's biotechnology in China Shanghai service company.Human brain cDNA is available from Clotech company, and TA clone test kit, baculovirus transfer vector pAcGP67b, liposome lipofectin are Invitrogen company product.Heparin Heparin affinity chromatography uses product available from Japan and Optical Chemical Company.Dna sequencing kit is purchased the Biosystems in PEApplied.The substratum TC-100 of foetal calf serum FCS, insect cell line Sf21 and the substratum 199 that is used for cultivator huve cell HUVEC are the product of GibcoBRL.Spodoptera frugiperda cell is that the substratum ESF921 of Tn-5 purchases the systems in Expression.Human umbilical vein endothelial cells HUVEC, SCS and ECGS are the product of Technoclone GmbH.The greedy frugiperda cell Sf21 in meadow uses the TC-100 substratum that adds 10% (v/v) FCS and 0.26% bacto-tryptone 27 ℃ of cultivations.Tn-5 utilizes the ESF921 of serum-free to cultivate based on cultivating in 27 ℃ of bottles.Silkworm hybrid is used in this test, and the silkworm larva mulberry leaf are raised, and temperature is 23～25 ℃.
2, workflow:
The recombinant human aFGF gene engineering expression in silkworm body production of being in
Method, it is characterized in that:
(1) clone of people aFGF gene: with human brain cDNA is template, and the pcr gene amplification technique obtains people aFGF gene, and design of primers is as follows: forward primer: 5 '-
AGATCTTTTAATCTGCCTCC-3 ' contains the BglII restriction enzyme site; Reverse primer: 5 '
AGATCTTTAATCAGAAGAGAC-3 ' contains the BglII restriction enzyme site.The cycle number of PCR reaction, the design of temperature and time are as follows: a circulation, 94 ℃ of template sex change 50 seconds; 30 circulations were annealed 30 seconds for 55 ℃, and 72 ℃ were extended 1 minute; Last 1 circulation, 72 ℃ were extended 10 minutes; Utilize 1% agarose gel electrophoresis to carry out the PCR product analysis, and with the PCR purification kit purifying of Qiagene, subsequently purpose PCR product cloning is gone into 3.9kb carrier pCR2.1, obtain pCR2.1-aFGF, utilize dideoxy chain termination on the nucleotide sequencing instrument, to check order and confirm human cloning aFGF gene order exactness;
(2) contain the structure of the recombinant baculovirus of people aFGF gene: pCR2.1-aFGF obtains people aFGF gene fragment with restriction enzyme BglII digestion, is cloned into baculovirus transfer vector pAcGP67b then and obtains recombinant chou pAcGP67b-aFGF; In insect cell, produce recombinant virus by cotransfection with hybridization baculovirus HyNPVDNA homologous recombination, the method of cotransfection is: 1 μ g pAcGP67b-aFGF DNA and 15 μ g HyNPV DNA mix, and add 14 μ l liposome lipofectin, add sterile purified water at last to final volume 40 μ l; Sf 21 culturing cells with this mixed solution cotransfection logarithmic phase after room temperature is cultivated 15 minutes.Earlier after 24 hours, change the fresh culture that contains 10% foetal calf serum into, cultivated 5 days for 27 ℃, collect the substratum supernatant, be used for recombinant celo virus as virus stock solution used with the TC-100 culture medium culturing of serum-free; Recombinant virus is taken turns plaque select by 3, finally obtains the viral solution of high density purifying, and concentration is 10
8Pfu/ml is with this recombinant virus called after HyNPV-aFGF;
(3) silkworm expression in vivo and recombinant human aFGF purifying: use silkworm larva to play silkworm 5 ages, inoculate above-mentioned recombinant virus and infect expression; Preceding larva is immersed in of inoculation carried out short period of time anesthesia in the ice-water bath, adopt hypodermic method injection recombinant virus suspension then, and concentration is 10
6Pfu/ml, every silkworm is injected 20 μ l, injects and feeds mulberry after 1 hour, and raise down at 23-25 ℃; Infect collector's silkworm larva in back 72-96 hour, dissect the fatty body of infected silkworm, and with this parent material as purification of recombinant human aFGF; The pH7.6 of precooling will be dissolved in after the fatty body homogenate, in the 20mM Tris-HCl damping fluid, behind high speed centrifugation, supernatant liquor directly gone up heparin Heparin affinity column, owing to people aFGF and heparin have the intensive affinity people aFGF is attached on the chromatography column, remove foreign protein with the above-mentioned same buffer solution elution that contains 0.4M NaCl then, the damping fluid one-step elution with 2.0MNaCl goes out bonded people aFGF at last.Identify recombinant protein by the SDS-PAGE electrophoretic analysis, the result shows that the recombinant human aFGF purity of acquisition is very high;
(4) recombinant human aFGF activation analysis is identified: the biological activity of analyzing recombinant human aFGF with Human umbilical vein endothelial cells HUVEC; Cell is 37 ℃ of cultivations in substratum 199, replenish 5% CO
2, add 100units/ml penicillin in the substratum in addition, the 100units/ml Streptomycin sulphate, the 4.0mg/ml amphotericin B, bovine serum is added in 20% hot deactivation, 5units/ml heparin and 50mg/ml endothelial cell growth supplementation material ECGS; Cell is inoculated in 24 hole tissue culturing plates after with tryptic digestion, and cell density is approximately 1.0 * 10
4Cells/well, every hole adds the same substratum of 1ml.After 24 hours, substratum is replaced by contains 10%SCS and 5units/ml heparin, but do not contain the fresh culture 199 of ECGS; The recombinant human aFGF of purifying with 0.22 μ m sterilising filter filtration sterilization, joins and cultivates in the plate hole behind gradient dilution, and every pore volume is no more than 10 μ l.After 72 hours, wash twice,, be resuspended among the 200 μ l PBS with centrifugal collecting cell behind the tryptic digestion with PBS; After 0.4% the blue dyeing of phenol, calculate number of cells with hemocytometer.The result shows that recombinant human aFGF can stimulate division, the propagation of HUVEC cell, shows that the recombinant human aFGF that expresses in the silkworm larva has biologic activity.
Claims (1)
1, the recombinant human aFGF method that gene engineering expression in silkworm body is produced of being in is characterized in that:
(1) clone of people aFGF gene: with human brain cDNA is template, and the pcr gene amplification technique obtains people aFGF gene, and design of primers is as follows: forward primer: 5 '-
AGATCTTTTAATCTGCCTCC-3 ' contains the BglII restriction enzyme site; Reverse primer: 5 '-
AGATCTTTAATCAGAAGAGAC-3 ' contains the BglII restriction enzyme site; The cycle number of PCR reaction, the design of temperature and time are as follows: a circulation, 94 ℃ of template sex change 50 seconds; 30 circulations were annealed 30 seconds for 55 ℃, and 72 ℃ were extended 1 minute; Last 1 circulation, 72 ℃ were extended 10 minutes; Utilize 1% agarose gel electrophoresis to carry out the PCR product analysis, and with PCR purification kit purifying, subsequently purpose PCR product cloning is gone into 3.9kb carrier pCR2.1, obtain pCR2.1-aFGF, utilize dideoxy chain termination on the nucleotide sequencing instrument, to check order and confirm human cloning aFGF gene order exactness;
(2) contain the structure of the recombinant baculovirus of people aFGF gene: pCR2.1-aFGF obtains people aFGF gene fragment with restriction enzyme BglII digestion, is cloned into baculovirus transfer vector pAcGP67b then and obtains recombinant chou pAcGP67b-aFGF; In insect cell, produce recombinant virus by cotransfection with hybridization baculovirus HyNPVDNA homologous recombination, the method of cotransfection is: 1 μ g pAcGP67b-aFGF DNA and 15 μ g HyNPV DNA mix, and add 14 μ l liposome lipofectin, add sterile purified water at last to final volume 40 μ l, with Sf 21 culturing cells of this mixed solution cotransfection logarithmic phase after room temperature is cultivated 15 minutes; Earlier after 24 hours, change the fresh culture that contains 10% foetal calf serum into, cultivated 5 days for 27 ℃, collect the substratum supernatant, be used for recombinant celo virus as virus stock solution used with the TC-100 culture medium culturing of serum-free; Recombinant virus is taken turns plaque select by 3, finally obtains the viral solution of high density purifying, and concentration is 108pfu/ml, with this recombinant virus called after HyNPV-aFGF;
(3) silkworm expression in vivo and recombinant human aFGF purifying: use silkworm larva to play silkworm 5 ages, inoculate above-mentioned recombinant virus and infect expression; Preceding larva is immersed in of inoculation carried out short period of time anesthesia in the ice-water bath, adopt hypodermic method injection recombinant virus suspension then, and concentration is 106pfu/ml, and every silkworm is injected 20 μ l, and inject and feed mulberry after 1 hour, and 23-25 ℃ of raising down; Infect collector's silkworm larva in back 72-96 hour, dissect the fatty body of infected silkworm, and with this parent material as purification of recombinant human aFGF; The pH7.6 of precooling will be dissolved in after the fatty body homogenate, in the 20mM Tris-HCl damping fluid, behind high speed centrifugation, supernatant liquor directly gone up heparin Heparin affinity column, owing to people aFGF and heparin have the intensive affinity people aFGF is attached on the chromatography column, remove foreign protein with the above-mentioned same buffer solution elution that contains 0.4M NaCl then, damping fluid one-step elution with 2.0M NaCl goes out bonded people aFGF at last, identify recombinant protein by the SDS-PAGE electrophoretic analysis, the result shows that the recombinant human aFGF purity of acquisition is very high;
(4) recombinant human aFGF activation analysis is identified: the biological activity of analyzing heavy people aFGF with Human umbilical vein endothelial cells HUVEC: Human umbilical vein endothelial cells HUVEC is 37 ℃ of cultivations in substratum 199, replenish 5% CO
2, bovine serum, 5units/ml heparin and 50mg/ml endothelial cell growth supplementation material ECGS are added in interpolation 100units/ml penicillin, 100units/ml Streptomycin sulphate, 4.0mg/ml amphotericin B, 20% hot deactivation in addition in the substratum; Above-mentioned cell is inoculated in 24 hole tissue culturing plates after with tryptic digestion, and cell density is approximately 1.0 * 10
4Cells/well, every hole adds the same substratum of 1ml; After 24 hours, with substratum be replaced by contain 10%SCS and 5units/ml heparin, but do not contain the fresh culture 199 of ECGS; The recombinant human aFGF of purifying with 0.22 μ m sterilising filter filtration sterilization, joins in the above-mentioned cultivation plate hole behind gradient dilution, and every pore volume is no more than 10 μ l; After 72 hours, wash twice,, be resuspended among the 200 μ l PBS with the above-mentioned cell of centrifugal collection behind the tryptic digestion with PBS; After 0.4% the blue dyeing of phenol, calculate number of cells with hemocytometer; The result shows that recombinant human aFGF can stimulate division, the propagation of above-mentioned cell, shows that the recombinant human aFGF that expresses in the silkworm larva has biologic activity.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510048965 CN1276081C (en) | 2005-01-13 | 2005-01-13 | Recombinant human aFGF production method by gene engineering expression in silkworm body |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510048965 CN1276081C (en) | 2005-01-13 | 2005-01-13 | Recombinant human aFGF production method by gene engineering expression in silkworm body |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1654648A CN1654648A (en) | 2005-08-17 |
| CN1276081C true CN1276081C (en) | 2006-09-20 |
Family
ID=34894499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510048965 Expired - Fee Related CN1276081C (en) | 2005-01-13 | 2005-01-13 | Recombinant human aFGF production method by gene engineering expression in silkworm body |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1276081C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104513821B (en) * | 2013-09-27 | 2017-06-06 | 西南大学 | The human acid fibroblast growth factor gene and its recombinant vector of transformation and application |
| CN115725590B (en) * | 2022-08-17 | 2024-04-05 | 西南大学 | Application and method of OSER1 gene in improving animal fertility or delaying reproductive aging |
-
2005
- 2005-01-13 CN CN 200510048965 patent/CN1276081C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1654648A (en) | 2005-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101376885A (en) | Method for producing recombinant canine interferon alpha from cultivated silkworm | |
| CN101629186B (en) | Method for producing recombinant scorpion toxin protein by adopting silkworm as parasitifer | |
| CN115521372A (en) | Triple-helix recombinant humanized type III collagen, preparation method and application | |
| CN112725270A (en) | Human-derived bone marrow mesenchymal stem cell induction culture medium and induction method | |
| CN102220338B (en) | Method for expressing human 2.5 S beta-nerve growth factor in human umbilical cord mesenchymal stem cell, and separating and purifying the human 2.5 S beta-nerve growth factor | |
| JP2024050477A (en) | Recombinant humanized collagen and its applications | |
| CN1276081C (en) | Recombinant human aFGF production method by gene engineering expression in silkworm body | |
| CN1277927C (en) | Method for preparing recombinant bFGF using domestic silkworm as biological factory | |
| CN101003802A (en) | Method for preparing maturation peptide of morphogenesis protein - 2 of human bones | |
| CN100371449C (en) | Structural method for improving gene engineering vector of recombinant silkworm nuclear polyhedron virus | |
| CN1277921C (en) | Method for producing recombinant human lactoferrin in silkworm body by gene engineering technology | |
| CN1772885A (en) | Method of inducing stem cell to differentiate into pancreatic island-like cell and application of pancreatic island-like cell | |
| CN1256430C (en) | Method for preparing recombinant vEGF using domestic silkworm as biological factory | |
| CN101037674A (en) | Rebuilt gland virus containing BMP-7 gene and usage thereof | |
| CN103333915A (en) | Vegetable oil skin care lotion containing basic fibroblast growth factor active peptide | |
| CN1844391A (en) | Nucleotide sequence for human morphogenetic protein 9 recombinant proteins and production method and use thereof | |
| CN100362103C (en) | Human epidermis factor nucleic sequence and use thereof | |
| CN101974536B (en) | Recombinant human interferon beta la gene, expression vector thereof and preparation method of recombinant human interferon beta la | |
| KR101896936B1 (en) | Serum-free medium for animal cell culture | |
| CN102776198A (en) | Method for expressing recombinant human bone morphogenetic protein in insect cell | |
| JP6048959B2 (en) | Production method of lysozyme | |
| CN107312789A (en) | A kind of preparation method of recombinant human bone morphogenesis protein | |
| JP6206873B2 (en) | Method for producing porcine lysozyme using secretory signal peptide derived from chicken lysozyme | |
| Baci et al. | Utilization of Transgenic Bombyx mori for Biomaterials Production | |
| CN1204145C (en) | Preparation of human vasal endothelial cell growth inhibitor and its application in tumor angiogenesis resisting treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |